Citius Pharmaceuticals Inc vs Sunrun Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.64M), while Sunrun Inc trades at $12.86 (market cap $3.05B). The key difference: Sunrun Inc is far larger — about 208.3× Citius Pharmaceuticals Inc's market cap, and Sunrun Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | RUN | |
|---|---|---|
Market Cap | $14.64M | $3.05B |
Sector | Health | Technology |
52-Week High | $1.82 | $21.41 |
52-Week Low | $0.53 | $9.07 |
Enterprise Value | $10.86M | $17.24B |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →